• China Pharma issued a statement following unusual trading in its common stock on July 21, 2026.
• NYSE American contacted the company under its standard process tied to unusual market activity.
• It said it was not aware of any material corporate developments that would explain the move.
• Investors were urged to use caution amid volatility, relying on SEC filings and company press releases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Pharma Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607211600PR_NEWS_USPR_____CN09503) on July 21, 2026, and is solely responsible for the information contained therein.